(EMAILWIRE.COM, October 27, 2018 ) According to the new market research “Cell-based Assays Market by Product (Reagents, Assay Kits, Microplates, Cell Lines, Service), Application (Research, Drug Discovery, ADME Studies, Toxicology), End User, and Region - Global Forecast to 2022", The cell-based assays market is expected to reach USD 19.92 Billion by 2022 from USD 13.34 Billion in 2017, at a CAGR of 8.4% during the forecast period from 2017 to 2022.

Don’t miss out on business opportunities in Cell-based Assays Market . Speak to our analyst and gain crucial industry insights that will help your business grow:
http://bit.ly/2R0x8qf

Factors driving the growth of this market are the increasing incidence of chronic disorders, growing availability of funds for research, and increase drug discovery research by the biopharmaceutical industries as well as contract research organizations.

Consumables segment is expected to dominate the market in 2017

On the basis of products, the cell-based assays market is segmented into consumables, instruments, services, and software. The consumables segment is expected to dominate the market in 2017. The increasing adoption of cell-based consumables by the key end users such as biopharmaceutical industries, contract research organizations and academic and research institutions is an important driver of the consumables segment in this market.

Browse and in-depth TOC on in “Cell-based Assays Market "
86 - Tables
48 - Figures
165 - Pages

View more detailed TOC @
https://www.marketsandmarkets.com/Market-Reports/cell-based-assays-market-119917269.html

Drug discovery is expected to command the largest market share in 2017
The cell-based assays market is segmented by applications into drug discovery, basic research, ADME studies, predictive toxicology and other segments. In 2017, the drug discovery segment is expected to account for the largest share of the cell-based assays market. The use of cell-based assays over traditional techniques for drug development and the clinical trial process across the globe is one of the major drivers for the growth of this segment.

Request for Free Sample Report @
http://bit.ly/2Oz9mFf

Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K), Thermo Fisher Scientific Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), BioTek Instruments, Inc. (U.S.), Lonza Group (U.S.), ProQinase GmbH (Germany), Charles River Laboratories, Inc (U.S.), Cisbio Bioassays (France), Miltenyi Biotec (Germany), Cell Biolabs, Inc. (U.S.), DiscoverX Corporation (U.S.), Marin Biologic Laboratories (U.S.), Biospherix, Ltd (U.S.), Essen BioScience Inc. (U.S.), Cell Biologics Inc. (U.S.), BioAgilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Aurelia Bioscience Ltd. (U.K.), Selexis SA (U.S.) are among a few major players in the cell-based assays market.

Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting


About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight:
https://www.marketsandmarkets.com/ResearchInsight/cell-based-assays-market.asp
Visit Our Website:
https://www.marketsandmarkets.com